Laura Rodríguez Gallego

Laura Rodríguez Gallego is an experienced professional in the biotechnology sector, currently serving as a board member and observer for multiple companies, including EsoBiotec, Telomere Therapeutics, OneChain Immunotherapeutics, and Gyala Therapeutics. With a strong background in investment and advisory roles at Invivo Partners and Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré, Laura has held positions ranging from investment analyst to partner since March 2019. Academic credentials include a PhD in Biotechnology and a Master's in Molecular Biotechnology from Universitat de Barcelona, complemented by a Bachelor's degree in Biotechnology from Universitat Autònoma de Barcelona.